The administration effect of Strobilanthes crispus extract (SC) during hepatocarcinogenesis was studied to investigate the possible cancer suppressive effect of the component existed in the leaves. The rats (84 male Sprague Dawley) were divided into 14 groups N (Normal), C (Cancer), NS I (Normal+ SC 1%), NS 2.5 (Normal+SC 2.5%), NS 5 (Normal+SC 5%), NS 7.5 (Normal+SC 7.5%), CS 1 (Cancer+SC 1%), CS 2.5 (Cancer+SC 2.5%), CS 5 (Cancer+SC 5%), CS 7.5 (Cancer+SC 7.5%), CG I (Cancer+Glycyrrhizin 1%), CG 2.5 (Cancer+Glycyrrhizin 2.5%), CG 5 (Cancer+Glycyrrhizin 5%), and CG 7.5 (Cancer+Glycyrrhizin 7.5%). 1, 2.5, 5 and 7.5% (w/v) of S. crispus extract were used, compared with Glycyrrhizin, the commercial anticancer drug used mainly for liver. Administration effect during liver cancer in rats that have been induced with cancer by diethylnitrosamine (DEN) and 2-acetyl-aminoflourence (AAF) was studied by estimation of glutathione S-transferase (GST) and uranyl diphosphate glucoronyl transferase (UDPGT) in liver. The severity of neoplasia in induced liver cancer was also evaluated by histological examination. Treatment with DEN/AAF caused increase in all enzyme activities measured when compared to control. Significant differences were observed among all the treatment groups for GST and UDPGT activities. Histological evaluations showed the loss of normal morphology and organizations of hepatocytes when carcinogens were introduced into the rats. The severity of liver cell dysplasia was evidently decreased by SC extract treatment group as compared to glycyrrhizin. Furthermore SC did not affect the normal organization in the liver. The findings suggest that supplementation’of SC on DEN/AAF rats reduced the severity of hepatocarcinogenesis.